US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (256)
  • Diseases & Conditions (6942)
  • Drug Delivery (230)
  • Therapeutic Area (9415)
  • Vaccines (752)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

5  6  7  8    10    12  13  14  
Mundiriz SA in Health and Wellness (Morocco)
7/18/2016 | published by: Euromonitor International
... to keep its distribution channels very wide and strong, as it sells through several distribution channels, including internet retailing and modern and traditional grocery retailers. Euromonitor International Local Company Profiles are a concise set of ...  |  read more...
USD 150
5-HT1 Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT1 Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT1A Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT1B Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT1F Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT2 Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT2C Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT4 Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5-HT4 Partial Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ...  |  read more...
USD 1,250
5-Lipoxygenase Inhibitors (Arachidonate 5-Lipoxygenase Inhibitors) -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ...  |  read more...
USD 1,250
Adenosine A2 Receptor Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, ...  |  read more...
USD 1,250
Adenosine A2A Receptor Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, ...  |  read more...
USD 1,250
Adenosine A3 Receptor Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, ...  |  read more...
USD 1,250
AmerisourceBergen Corp.
8/1/2016 | published by: SGA ExecutiveTracker
... US Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers ...  |  read more...
USD 165
Adrenergic Uptake Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Akt2 Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Nicotinic Receptor (NNR) Agonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information ...  |  read more...
USD 1,250
Alpha Receptor Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration
7/21/2016 | published by: MarketsandMarkets
... Wholesalers, GPOs, Manufacturers), By Purchasing Organization (Hospitals, GPOs), By Transaction (ORDERS, ORDERSP, DESADV, RECADV, INVOIC)] – Transaction Types and Its Penetration” EDI provides fast, secure, and easy exchange of information between healthcare organizations. These advantages ...  |  read more...
USD 5,650
Alpha Tubulin Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Alpha-1 Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Alpha-1A Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Alpha-1A Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
5  6  7  8    10    12  13  14